A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept.

Authors:
Nevermann N; Bode J; Vischer M; Feldbrügge L; Knitter S and 8 more

Journal:
Langenbecks Arch Surg

Publication Year: 2023

DOI:
10.1007/s00423-023-03023-y

PMCID:
PMC10404569

PMID:
37544932

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Langenbecks Arch Surg

Abbreviation: Langenbecks Arch Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anomalies of the right hepatic artery in periampullary cancer treatment: are pathological and clini…
De Sio D; Lucinato C; Panza E and 11 more (2024) - Transparency Score: 3/6
Approach to concurrent inguinal hernias during laparoscopic appendectomy for early appendicitis.
Dayı S; Anayurt M; Çınar F and 2 more (2024) - Transparency Score: 3/6
Endoscopic and surgical treatment of necrotizing pancreatitis-a comparison of short- and long-term …
Timmermann L; Schönauer S; Hillebrandt KH and 4 more (2024) - Transparency Score: 3/6
Management of groin hernias in emergency setting: differences in indications and outcomes between l…
Sbacco V; Petrucciani N; Lauteri G and 4 more (2024) - Transparency Score: 3/6
Management of intraoperatively identified small bile duct stones in patients undergoing cholecystec…
Bunting D; Adesuyi A; Findlay J and 2 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsProfessor Johann Pratschke received a research grant from the Intuitive Surgical Deutschland GmbH for the conduction of the present study. Furthermore, he reports personal fees or other support from Johnson & Johnson, Medtronic, Astellas, CHG Meridian, AFS Medical, Chiesi, Falk Foundation, Neovii, NOGGO, pharma-consult Peterson, La Fource Group, Merck and promedicis.Professor Moritz Schmelzle reports personal fees or non-financial support outside of the submitted work from the Merck Serono GmbH, Bayer AG, ERBE Elektromedizin GmbH, Amgen Inc., Johnson&Johnson Medical GmbH, ERBE Elektromedizin GmbH, Takeda Pharmaceutical Limited, Olympus K.K., Medtronic GmbH, Intuitive Surgical Inc.Drs. Nora Nevermann, Julia Bode, Maxine Vischer, Linda Feldbrügge, Sebastian Knitter, Felix Krenzien, Uwe Pelzer, Uli Fehrenbach, Timo Auer, Georg Lurje, and Professor Wenzel Schöning have no conflicts of interest or financial ties to disclose. Competing interests Professor Johann Pratschke received a research grant from the Intuitive Surgical Deutschland GmbH for the conduction of the present study. Furthermore, he reports personal fees or other support from Johnson & Johnson, Medtronic, Astellas, CHG Meridian, AFS Medical, Chiesi, Falk Foundation, Neovii, NOGGO, pharma-consult Peterson, La Fource Group, Merck and promedicis. Professor Moritz Schmelzle reports personal fees or non-financial support outside of the submitted work from the Merck Serono GmbH, Bayer AG, ERBE Elektromedizin GmbH, Amgen Inc., Johnson&Johnson Medical GmbH, ERBE Elektromedizin GmbH, Takeda Pharmaceutical Limited, Olympus K.K., Medtronic GmbH, Intuitive Surgical Inc. Drs. Nora Nevermann, Julia Bode, Maxine Vischer, Linda Feldbrügge, Sebastian Knitter, Felix Krenzien, Uwe Pelzer, Uli Fehrenbach, Timo Auer, Georg Lurje, and Professor Wenzel Schöning have no conflicts of interest or financial ties to disclose."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025